Venous Thromboembolism

>

The HCPLive venous thromboembolism page is a resource for medical news and expert insights on VTE. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.

Latest News

Marc S. Sabatine, MD, MPH | Credit: Brigham and Women's Hospital
Abelacimab Demonstrates "Overwhelming" Efficacy vs Rivaroxaban in Phase 2b Trial

September 18th 2023

Anthos Therapeutics halts their phase 2 AZALEA-TIMI 71 trial due to significant reduction in bleeding events with abelacimab, making it a potential breakthrough in anticoagulation therapy for atrial fibrillation.

Stock image of an aspirin tablet
Aspirin Deemed as Effective as Heparin in Patients Hospitalized with Traumatic Fractures

January 18th 2023

Reducing Aspirin Use Improves Outcomes in Patients with AF, VTE Receiving Warfarin
Reducing Aspirin Use Improves Outcomes in Patients with AF, VTE Receiving Warfarin

September 20th 2022

No Clear Risk for VTE in Eczema Patients Receiving JAK Inhibitors
No Clear Risk for VTE in Eczema Patients Receiving JAK Inhibitors

August 24th 2022

Continuous VTE Risk Observed After Lower Extremity Revascularization in Patients with PAD
Continuous VTE Risk Observed After Lower Extremity Revascularization in Patients with PAD

July 6th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.